Tech Company Financing Transactions
PathoGenetix Funding Round
PathoGenetix secured a $10 million Series C funding round on 10/30/2013. Backers included Ascension Ventures, Excel Venture Management and HealthCare Ventures.
Transaction Overview
Company Name
Announced On
10/30/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series C
Investors
Ascension Ventures (Tara Butler)
Excel Venture Management (Enrico Petrillo)
HealthCare Ventures (Gus Lawlor)
Proceeds Purpose
Proceeds purposes will be used to fund continued efforts to commercialize its Genome Sequence Scanning (GSS) technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
580 Pleasant St.
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
PathoGenetix has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ann Merrifield
VP - Bus. Development
John Czajka
VP - Engineering
John Luckey
VP - R & D
Rudolf Gilmanshin
Browse more venture capital transactions:
Prev: 10/29/2013: Magisto venture capital transaction
Next: 10/30/2013: Apse venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs